A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLL
NCT01750567
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
37
Enrollment
OTHER
Sponsor class
Conditions
Relapsed Chronic Lymphocytic Leukemia
Interventions
DRUG:
Metformin
Sponsor
University of Michigan Rogel Cancer Center